サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121971

世界の非侵襲性出生前検査市場：考察と予測 (2028年まで)

Global Non-Invasive Prenatal Testing Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 102 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
世界の非侵襲性出生前検査市場：考察と予測 (2028年まで)
出版日: 2022年09月06日
発行: QYResearch
ページ情報: 英文 102 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、非侵襲性出生前検査 (Non-Invasive Prenatal Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の非侵襲性出生前検査の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • High & Average Risk
    • Low Risk
  • 市場：アプリケーション別
    • 世界の非侵襲性出生前検査の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • 0-12 Weeks
    • 13-24 Weeks
    • 25-36 Weeks
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の非侵襲性出生前検査の市場展望 (2017-2028)
  • 非侵襲性出生前検査の市場成長トレンド：地域別
    • 非侵襲性出生前検査 市場規模：地域別: 2017 VS 2021 VS 2028
    • 非侵襲性出生前検査の市場規模実績：地域別 (2017-2022)
    • 非侵襲性出生前検査の市場規模予測：地域別 (2023-2028)
  • 非侵襲性出生前検査 市場動向
    • 非侵襲性出生前検査 業界動向
    • 非侵襲性出生前検査 市場の促進要因
    • 非侵襲性出生前検査 市場の課題
    • 非侵襲性出生前検査 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の非侵襲性出生前検査の上位企業：収益別
    • 世界の非侵襲性出生前検査の上位企業：収益別 (2017-2022)
    • 世界の非侵襲性出生前検査の収益シェア：企業別 (2017-2022)
  • 世界の非侵襲性出生前検査の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：非侵襲性出生前検査の収益
  • 世界の非侵襲性出生前検査 市場集中度
    • 世界の非侵襲性出生前検査 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 非侵襲性出生前検査の収益 2021
  • 非侵襲性出生前検査の主要企業の本社および事業エリア
  • 主要企業 非侵襲性出生前検査の製品ソリューションおよびサービス
  • 市場参入時期： 非侵襲性出生前検査 市場
  • M&A, 拡張計画

第4章 非侵襲性出生前検査 内訳データ：タイプ別

  • 世界の非侵襲性出生前検査の市場規模実績：タイプ別 (2017-2022)
  • 世界の非侵襲性出生前検査の市場規模予測：タイプ別 (2023-2028)

第5章 非侵襲性出生前検査 内訳データ：アプリケーション別

  • 世界の非侵襲性出生前検査の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の非侵襲性出生前検査の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の非侵襲性出生前検査 市場規模 (2017-2028)
  • 北米の非侵襲性出生前検査 市場規模：タイプ別
    • 北米の非侵襲性出生前検査 市場規模：タイプ別 (2017-2022)
    • 北米の非侵襲性出生前検査 市場規模：タイプ別 (2023-2028)
    • 北米の非侵襲性出生前検査の市場シェア：タイプ別 (2017-2028)
  • 北米の非侵襲性出生前検査 市場規模：アプリケーション別
    • 北米の非侵襲性出生前検査 市場規模：アプリケーション別 (2017-2022)
    • 北米の非侵襲性出生前検査 市場規模：アプリケーション別 (2023-2028)
    • 北米の非侵襲性出生前検査の市場シェア：アプリケーション別 (2017-2028)
  • 北米の非侵襲性出生前検査 市場規模：国別
    • 北米の非侵襲性出生前検査 市場規模：国別 (2017-2022)
    • 北米の非侵襲性出生前検査 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の非侵襲性出生前検査 市場規模 (2017-2028)
  • 欧州の非侵襲性出生前検査 市場規模：タイプ別
    • 欧州の非侵襲性出生前検査 市場規模：タイプ別 (2017-2022)
    • 欧州の非侵襲性出生前検査 市場規模：タイプ別 (2023-2028)
    • 欧州の非侵襲性出生前検査の市場シェア：タイプ別 (2017-2028)
  • 欧州の非侵襲性出生前検査 市場規模：アプリケーション別
    • 欧州の非侵襲性出生前検査 市場規模：アプリケーション別 (2017-2022)
    • 欧州の非侵襲性出生前検査 市場規模：アプリケーション別 (2023-2028)
    • 欧州の非侵襲性出生前検査の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の非侵襲性出生前検査 市場規模：国別
    • 欧州の非侵襲性出生前検査 市場規模：国別 (2017-2022)
    • 欧州の非侵襲性出生前検査 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 非侵襲性出生前検査 市場規模 (2017-2028)
  • アジア太平洋地域 非侵襲性出生前検査 市場規模：タイプ別
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 非侵襲性出生前検査の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 非侵襲性出生前検査 市場規模：アプリケーション別
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 非侵襲性出生前検査の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 非侵襲性出生前検査 市場規模：地域別
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 非侵襲性出生前検査 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの非侵襲性出生前検査 市場規模 (2017-2028)
  • ラテンアメリカの非侵襲性出生前検査 市場規模：タイプ別
    • ラテンアメリカの非侵襲性出生前検査 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの非侵襲性出生前検査 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの非侵襲性出生前検査の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの非侵襲性出生前検査 市場規模：アプリケーション別
    • ラテンアメリカの非侵襲性出生前検査 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの非侵襲性出生前検査 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの非侵襲性出生前検査の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの非侵襲性出生前検査 市場規模：国別
    • ラテンアメリカの非侵襲性出生前検査 市場規模：国別 (2017-2022)
    • ラテンアメリカの非侵襲性出生前検査 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの非侵襲性出生前検査 市場規模 (2017-2028)
  • 中東・アフリカの非侵襲性出生前検査 市場規模：タイプ別
    • 中東・アフリカの非侵襲性出生前検査 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの非侵襲性出生前検査 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの非侵襲性出生前検査の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの非侵襲性出生前検査 市場規模：アプリケーション別
    • 中東・アフリカの非侵襲性出生前検査 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの非侵襲性出生前検査 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの非侵襲性出生前検査の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの非侵襲性出生前検査 市場規模：国別
    • 中東・アフリカの非侵襲性出生前検査 市場規模：国別 (2017-2022)
    • 中東・アフリカの非侵襲性出生前検査 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Sequenom
  • Roche
  • Natera
  • LabCorp
  • BGI Genomics
  • Quest Diagnostics
  • Illumina
  • Berry Genomics

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of High & Average Risk
  • Table 3. Key Players of Low Risk
  • Table 4. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Non-Invasive Prenatal Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Non-Invasive Prenatal Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Non-Invasive Prenatal Testing Market Share by Region (2017-2022)
  • Table 8. Global Non-Invasive Prenatal Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Non-Invasive Prenatal Testing Market Share by Region (2023-2028)
  • Table 10. Non-Invasive Prenatal Testing Market Trends
  • Table 11. Non-Invasive Prenatal Testing Market Drivers
  • Table 12. Non-Invasive Prenatal Testing Market Challenges
  • Table 13. Non-Invasive Prenatal Testing Market Restraints
  • Table 14. Global Non-Invasive Prenatal Testing Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Non-Invasive Prenatal Testing Revenue Share by Players (2017-2022)
  • Table 16. Global Top Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2021)
  • Table 17. Ranking of Global Top Non-Invasive Prenatal Testing Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Non-Invasive Prenatal Testing Product Solution and Service
  • Table 21. Date of Enter into Non-Invasive Prenatal Testing Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2017-2022)
  • Table 25. Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2023-2028)
  • Table 27. Global Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Non-Invasive Prenatal Testing Revenue Share by Application (2017-2022)
  • Table 29. Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Non-Invasive Prenatal Testing Revenue Share by Application (2023-2028)
  • Table 31. North America Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Non-Invasive Prenatal Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Non-Invasive Prenatal Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Non-Invasive Prenatal Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Non-Invasive Prenatal Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Non-Invasive Prenatal Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Non-Invasive Prenatal Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Non-Invasive Prenatal Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Non-Invasive Prenatal Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Non-Invasive Prenatal Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Non-Invasive Prenatal Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Non-Invasive Prenatal Testing Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Non-Invasive Prenatal Testing Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Non-Invasive Prenatal Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Non-Invasive Prenatal Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Non-Invasive Prenatal Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Non-Invasive Prenatal Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Non-Invasive Prenatal Testing Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Sequenom Company Details
  • Table 62. Sequenom Business Overview
  • Table 63. Sequenom Non-Invasive Prenatal Testing Product
  • Table 64. Sequenom Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 65. Sequenom Recent Developments
  • Table 66. Roche Company Details
  • Table 67. Roche Business Overview
  • Table 68. Roche Non-Invasive Prenatal Testing Product
  • Table 69. Roche Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 70. Roche Recent Developments
  • Table 71. Natera Company Details
  • Table 72. Natera Business Overview
  • Table 73. Natera Non-Invasive Prenatal Testing Product
  • Table 74. Natera Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 75. Natera Recent Developments
  • Table 76. LabCorp Company Details
  • Table 77. LabCorp Business Overview
  • Table 78. LabCorp Non-Invasive Prenatal Testing Product
  • Table 79. LabCorp Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 80. LabCorp Recent Developments
  • Table 81. BGI Genomics Company Details
  • Table 82. BGI Genomics Business Overview
  • Table 83. BGI Genomics Non-Invasive Prenatal Testing Product
  • Table 84. BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 85. BGI Genomics Recent Developments
  • Table 86. Quest Diagnostics Company Details
  • Table 87. Quest Diagnostics Business Overview
  • Table 88. Quest Diagnostics Non-Invasive Prenatal Testing Product
  • Table 89. Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 90. Quest Diagnostics Recent Developments
  • Table 91. Illumina Company Details
  • Table 92. Illumina Business Overview
  • Table 93. Illumina Non-Invasive Prenatal Testing Product
  • Table 94. Illumina Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 95. Illumina Recent Developments
  • Table 96. Berry Genomics Company Details
  • Table 97. Berry Genomics Business Overview
  • Table 98. Berry Genomics Non-Invasive Prenatal Testing Product
  • Table 99. Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2017-2022) & (US$ Million)
  • Table 100. Berry Genomics Recent Developments
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Non-Invasive Prenatal Testing Market Share by Type: 2021 VS 2028
  • Figure 2. High & Average Risk Features
  • Figure 3. Low Risk Features
  • Figure 4. Global Non-Invasive Prenatal Testing Market Share by Application: 2021 VS 2028
  • Figure 5. 0-12 Weeks Case Studies
  • Figure 6. 13-24 Weeks Case Studies
  • Figure 7. 25-36 Weeks Case Studies
  • Figure 8. Non-Invasive Prenatal Testing Report Years Considered
  • Figure 9. Global Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Non-Invasive Prenatal Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Non-Invasive Prenatal Testing Market Share by Region: 2021 VS 2028
  • Figure 12. Global Non-Invasive Prenatal Testing Market Share by Players in 2021
  • Figure 13. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Revenue in 2021
  • Figure 15. North America Non-Invasive Prenatal Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Non-Invasive Prenatal Testing Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Non-Invasive Prenatal Testing Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Non-Invasive Prenatal Testing Market Size Share by Country (2017-2028)
  • Figure 19. United States Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Non-Invasive Prenatal Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Non-Invasive Prenatal Testing Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Non-Invasive Prenatal Testing Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Non-Invasive Prenatal Testing Market Size Share by Country (2017-2028)
  • Figure 25. Germany Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Non-Invasive Prenatal Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Non-Invasive Prenatal Testing Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Non-Invasive Prenatal Testing Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Non-Invasive Prenatal Testing Market Size Share by Region (2017-2028)
  • Figure 35. China Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 41. Latin America Non-Invasive Prenatal Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Non-Invasive Prenatal Testing Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Non-Invasive Prenatal Testing Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Non-Invasive Prenatal Testing Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Non-Invasive Prenatal Testing Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Non-Invasive Prenatal Testing Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Non-Invasive Prenatal Testing Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Non-Invasive Prenatal Testing Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Non-Invasive Prenatal Testing Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 55. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 56. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 57. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 58. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 59. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 60. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 61. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2017-2022)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed
目次

This research report focuses on the Non-Invasive Prenatal Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 High & Average Risk
    • 1.2.3 Low Risk
  • 1.3 Market by Application
    • 1.3.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 0-12 Weeks
    • 1.3.3 13-24 Weeks
    • 1.3.4 25-36 Weeks
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Non-Invasive Prenatal Testing Market Perspective (2017-2028)
  • 2.2 Non-Invasive Prenatal Testing Growth Trends by Region
    • 2.2.1 Non-Invasive Prenatal Testing Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Non-Invasive Prenatal Testing Historic Market Size by Region (2017-2022)
    • 2.2.3 Non-Invasive Prenatal Testing Forecasted Market Size by Region (2023-2028)
  • 2.3 Non-Invasive Prenatal Testing Market Dynamics
    • 2.3.1 Non-Invasive Prenatal Testing Industry Trends
    • 2.3.2 Non-Invasive Prenatal Testing Market Drivers
    • 2.3.3 Non-Invasive Prenatal Testing Market Challenges
    • 2.3.4 Non-Invasive Prenatal Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Non-Invasive Prenatal Testing Players by Revenue
    • 3.1.1 Global Top Non-Invasive Prenatal Testing Players by Revenue (2017-2022)
    • 3.1.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2017-2022)
  • 3.2 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Non-Invasive Prenatal Testing Revenue
  • 3.4 Global Non-Invasive Prenatal Testing Market Concentration Ratio
    • 3.4.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2021
  • 3.5 Non-Invasive Prenatal Testing Key Players Head office and Area Served
  • 3.6 Key Players Non-Invasive Prenatal Testing Product Solution and Service
  • 3.7 Date of Enter into Non-Invasive Prenatal Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Invasive Prenatal Testing Breakdown Data by Type

  • 4.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2017-2022)
  • 4.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2023-2028)

5 Non-Invasive Prenatal Testing Breakdown Data by Application

  • 5.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2017-2022)
  • 5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Non-Invasive Prenatal Testing Market Size (2017-2028)
  • 6.2 North America Non-Invasive Prenatal Testing Market Size by Type
    • 6.2.1 North America Non-Invasive Prenatal Testing Market Size by Type (2017-2022)
    • 6.2.2 North America Non-Invasive Prenatal Testing Market Size by Type (2023-2028)
    • 6.2.3 North America Non-Invasive Prenatal Testing Market Share by Type (2017-2028)
  • 6.3 North America Non-Invasive Prenatal Testing Market Size by Application
    • 6.3.1 North America Non-Invasive Prenatal Testing Market Size by Application (2017-2022)
    • 6.3.2 North America Non-Invasive Prenatal Testing Market Size by Application (2023-2028)
    • 6.3.3 North America Non-Invasive Prenatal Testing Market Share by Application (2017-2028)
  • 6.4 North America Non-Invasive Prenatal Testing Market Size by Country
    • 6.4.1 North America Non-Invasive Prenatal Testing Market Size by Country (2017-2022)
    • 6.4.2 North America Non-Invasive Prenatal Testing Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Non-Invasive Prenatal Testing Market Size (2017-2028)
  • 7.2 Europe Non-Invasive Prenatal Testing Market Size by Type
    • 7.2.1 Europe Non-Invasive Prenatal Testing Market Size by Type (2017-2022)
    • 7.2.2 Europe Non-Invasive Prenatal Testing Market Size by Type (2023-2028)
    • 7.2.3 Europe Non-Invasive Prenatal Testing Market Share by Type (2017-2028)
  • 7.3 Europe Non-Invasive Prenatal Testing Market Size by Application
    • 7.3.1 Europe Non-Invasive Prenatal Testing Market Size by Application (2017-2022)
    • 7.3.2 Europe Non-Invasive Prenatal Testing Market Size by Application (2023-2028)
    • 7.3.3 Europe Non-Invasive Prenatal Testing Market Share by Application (2017-2028)
  • 7.4 Europe Non-Invasive Prenatal Testing Market Size by Country
    • 7.4.1 Europe Non-Invasive Prenatal Testing Market Size by Country (2017-2022)
    • 7.4.2 Europe Non-Invasive Prenatal Testing Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size (2017-2028)
  • 8.2 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Type
    • 8.2.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Non-Invasive Prenatal Testing Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Application
    • 8.3.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Non-Invasive Prenatal Testing Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region
    • 8.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Non-Invasive Prenatal Testing Market Size (2017-2028)
  • 9.2 Latin America Non-Invasive Prenatal Testing Market Size by Type
    • 9.2.1 Latin America Non-Invasive Prenatal Testing Market Size by Type (2017-2022)
    • 9.2.2 Latin America Non-Invasive Prenatal Testing Market Size by Type (2023-2028)
    • 9.2.3 Latin America Non-Invasive Prenatal Testing Market Share by Type (2017-2028)
  • 9.3 Latin America Non-Invasive Prenatal Testing Market Size by Application
    • 9.3.1 Latin America Non-Invasive Prenatal Testing Market Size by Application (2017-2022)
    • 9.3.2 Latin America Non-Invasive Prenatal Testing Market Size by Application (2023-2028)
    • 9.3.3 Latin America Non-Invasive Prenatal Testing Market Share by Application (2017-2028)
  • 9.4 Latin America Non-Invasive Prenatal Testing Market Size by Country
    • 9.4.1 Latin America Non-Invasive Prenatal Testing Market Size by Country (2017-2022)
    • 9.4.2 Latin America Non-Invasive Prenatal Testing Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size (2017-2028)
  • 10.2 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Type
    • 10.2.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Non-Invasive Prenatal Testing Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Application
    • 10.3.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Non-Invasive Prenatal Testing Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country
    • 10.4.1 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Non-Invasive Prenatal Testing Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sequenom
    • 11.1.1 Sequenom Company Details
    • 11.1.2 Sequenom Business Overview
    • 11.1.3 Sequenom Non-Invasive Prenatal Testing Introduction
    • 11.1.4 Sequenom Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.1.5 Sequenom Recent Developments
  • 11.2 Roche
    • 11.2.1 Roche Company Details
    • 11.2.2 Roche Business Overview
    • 11.2.3 Roche Non-Invasive Prenatal Testing Introduction
    • 11.2.4 Roche Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.2.5 Roche Recent Developments
  • 11.3 Natera
    • 11.3.1 Natera Company Details
    • 11.3.2 Natera Business Overview
    • 11.3.3 Natera Non-Invasive Prenatal Testing Introduction
    • 11.3.4 Natera Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.3.5 Natera Recent Developments
  • 11.4 LabCorp
    • 11.4.1 LabCorp Company Details
    • 11.4.2 LabCorp Business Overview
    • 11.4.3 LabCorp Non-Invasive Prenatal Testing Introduction
    • 11.4.4 LabCorp Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.4.5 LabCorp Recent Developments
  • 11.5 BGI Genomics
    • 11.5.1 BGI Genomics Company Details
    • 11.5.2 BGI Genomics Business Overview
    • 11.5.3 BGI Genomics Non-Invasive Prenatal Testing Introduction
    • 11.5.4 BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.5.5 BGI Genomics Recent Developments
  • 11.6 Quest Diagnostics
    • 11.6.1 Quest Diagnostics Company Details
    • 11.6.2 Quest Diagnostics Business Overview
    • 11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Introduction
    • 11.6.4 Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.6.5 Quest Diagnostics Recent Developments
  • 11.7 Illumina
    • 11.7.1 Illumina Company Details
    • 11.7.2 Illumina Business Overview
    • 11.7.3 Illumina Non-Invasive Prenatal Testing Introduction
    • 11.7.4 Illumina Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.7.5 Illumina Recent Developments
  • 11.8 Berry Genomics
    • 11.8.1 Berry Genomics Company Details
    • 11.8.2 Berry Genomics Business Overview
    • 11.8.3 Berry Genomics Non-Invasive Prenatal Testing Introduction
    • 11.8.4 Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2017-2022)
    • 11.8.5 Berry Genomics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer